ZNF805 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.991000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.299200E-01
Normal-vs-Stage2
6.725800E-01
Normal-vs-Stage3
4.112000E-01
Normal-vs-Stage4
4.863800E-01
Stage1-vs-Stage2
9.702200E-01
Stage1-vs-Stage3
4.563200E-01
Stage1-vs-Stage4
9.185500E-02
Stage2-vs-Stage3
5.078400E-01
Stage2-vs-Stage4
1.719150E-01
Stage3-vs-Stage4
1.268550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.262200E-01
Normal-vs-AfricanAmerican
6.309200E-01
Normal-vs-Asian
4.788600E-01
Caucasian-vs-AfricanAmerican
8.769800E-01
Caucasian-vs-Asian
3.673200E-01
AfricanAmerican-vs-Asian
6.608600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.559800E-01
Normal-vs-Female
6.301800E-01
Male-vs-Female
7.079200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.078800E-01
Normal-vs-Age(41-60Yrs)
8.577800E-01
Normal-vs-Age(61-80Yrs)
5.917400E-01
Normal-vs-Age(81-100Yrs)
4.249700E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.149800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.766600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.313400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.116300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.54369999999715E-05
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.608080E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.133800E-01
Normal-vs-Daily Drinker
4.629800E-01
Normal-vs-Weekly Drinker
7.964600E-01
Normal-vs-Occasional Drinker
8.397800E-01
Normal-vs-Social Drinker
8.651800E-01
Non Drinker-vs-Daily Drinker
8.234800E-01
Non Drinker-vs-Weekly Drinker
3.593600E-01
Non Drinker-vs-Occasional Drinker
8.034200E-02
Non Drinker-vs-Social Drinker
2.785800E-01
Daily Drinker-vs-Weekly Drinker
3.832400E-01
Daily Drinker-vs-Occasional Drinker
7.061900E-02
Daily Drinker-vs-Social Drinker
2.889200E-01
Weekly Drinker-vs-Occasional Drinker
4.175600E-01
Weekly Drinker-vs-Social Drinker
8.757600E-01
Occasional Drinker-vs-Social Drinker
5.069400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.619800E-01
Normal-vs-Grade 2
8.400600E-01
Normal-vs-Grade 3
8.572600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.583200E-01
Grade 1-vs-Grade 3
9.375200E-01
Grade 1-vs-Grade 4
6.619800E-01
Grade 2-vs-Grade 3
7.250000E-01
Grade 2-vs-Grade 4
8.400600E-01
Grade 3-vs-Grade 4
8.572600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.633000E-01
Normal-vs-NonDiabetic
7.602800E-01
Diabetic-vs-NonDiabetic
2.541600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.115400E-01
Normal-vs-NoPancreatitis
7.000600E-01
Pancreatitis-vs-NoPancreatitis
6.391600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.616600E-01
Normal-vs-N1
7.156000E-01
N0-vs-N1
9.157200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.834000E-01
Normal-vs-TP53-NonMutant
5.614600E-01
TP53-Mutant-vs-TP53-NonMutant
3.216600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
